Trials / Completed
CompletedNCT01007708
The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 780 (actual)
- Sponsor
- Dow Pharmaceutical Sciences · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-108 | Topical application once a day for 48 weeks |
| DRUG | Vehicle | Topical application once a day for 48 weeks |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2009-11-04
- Last updated
- 2012-06-22
Locations
44 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01007708. Inclusion in this directory is not an endorsement.